Open | - |
Close | - |
Volume / Avg. | 354.000 / 580.745K |
Day Range | - - - |
52 Wk Range | 1.430 - 6.850 |
Market Cap | $243.074M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 5.8% |
Days to Cover | 2.13 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Black Diamond Therapeutic (NASDAQ: BDTX) through any online brokerage.
Other companies in Black Diamond Therapeutic’s space includes: bluebird bio (NASDAQ:BLUE), Inovio Pharmaceuticals (NASDAQ:INO), Gritstone Bio (NASDAQ:GRTS), Mesoblast (NASDAQ:MESO) and Agenus (NASDAQ:AGEN).
The latest price target for Black Diamond Therapeutic (NASDAQ: BDTX) was reported by HC Wainwright & Co. on Monday, March 18, 2024. The analyst firm set a price target for 12.00 expecting BDTX to rise to within 12 months (a possible 155.32% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Black Diamond Therapeutic (NASDAQ: BDTX) is $4.7 last updated Today at March 19, 2024 at 7:07 AM EDT.
There are no upcoming dividends for Black Diamond Therapeutic.
Black Diamond Therapeutic’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Black Diamond Therapeutic.
Black Diamond Therapeutic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.